A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia

Mark R. Litzow, Sandra Lee, John M. Bennett, Gordon W. Dewald, Robert E. Gallagher, Vibha Jain, Elisabeth M. Paietta, Janis Racevskis, Steven R. Rousey, Joseph J. Mazza, Martin S. Tallman

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences